Growel Remedies Limited

• Board approved preferential issue of 3.72 lakh equity shares at ₹250/share to public allottees, raising ₹9.3 crore. • Approved issue of 9.48 lakh convertible warrants at ₹250/warrant to promoters &

Board approved preferential issue of 3.72 lakh equity shares at ₹250 each to public investors, raising ₹9.3 crore. Approved issue of 9.48 lakh convertible warrants at ₹250 each to promoters and public